ORAL PREMALIGNANT LESION

Clinical trials for ORAL PREMALIGNANT LESION explained in plain language.

Never miss a new study

Get alerted when new ORAL PREMALIGNANT LESION trials appear

Sign up with your email to follow new studies for ORAL PREMALIGNANT LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Cancer drug injected directly into precancerous mouth spots shows promise in early trial

Disease control Ongoing

This early-phase trial tests whether injecting the cancer drug nivolumab directly into high-risk precancerous mouth lesions is safe and can shrink them. The study involves 18 adults with untreated oral lesions. The goal is to see if this local approach can reduce the risk of thes…

Matched conditions: ORAL PREMALIGNANT LESION

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:06 UTC

ORAL PREMALIGNANT LESION

Get alerted when new ORAL PREMALIGNANT LESION trials appear

Cancer drug injected directly into precancerous mouth spots shows promise in early trial